Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.
A recent genome-wide association study (GWAS) performed by the The Wellcome Trust Case-Control Consortium based on 12 374 nonsynonymous single-nucleotide polymorphisms (SNPs) provided evidence for several genes involved in multiple sclerosis (MS) susceptibility. In this study, we aimed at verifying...
Main Authors: | Alcina, A, Ramagopalan, S, Fernández, O, Catalá-Rabasa, A, Fedetz, M, Ndagire, D, Leyva, L, Arnal, C, Delgado, C, Lucas, M, Izquierdo, G, Ebers, G, Matesanz, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Replication analysis identifies a new multiple sclerosis susceptibility factor at the chromosome 1p36.22 region
by: Alcina, A, et al.
Published: (2009) -
An autosomal glucose-6-phosphate dehydrogenase (hexose-6-phosphate dehydrogenase) polymorphism in human saliva
by: Tan, Soon Guan, et al.
Published: (1976) -
Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue.
by: Bujalska, I, et al.
Published: (2008) -
Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
by: Bujalska, I, et al.
Published: (2005) -
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
by: Draper, N, et al.
Published: (2003)